McNamara, Harold M. https://orcid.org/0009-0006-6593-6477
Solley, Sabrina C. https://orcid.org/0000-0002-2356-5608
Adamson, Britt https://orcid.org/0000-0002-9451-5819
Chan, Michelle M. https://orcid.org/0000-0001-9451-9716
Toettcher, Jared E. https://orcid.org/0000-0002-1546-4030
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (U01DK127429)
NSF | Directorate for Biological Sciences (2134935)
NSF | Directorate for Mathematical & Physical Sciences | Division of Physics (1734030)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (T32GM007388)
Article History
Received: 19 October 2023
Accepted: 5 September 2024
First Online: 2 October 2024
Competing interests
: J.E.T. is a scientific advisor for Prolific Machines and Nereid Therapeutics. B.A. is an advisory board member with options for Arbor Biotechnologies and Tessera Therapeutics, and holds equity in Celsius Therapeutics. H.M.M. is a cofounder and scientific advisor for C16 Biosciences. The remaining authors declare no conflicts of interest.